Back to Top

Myeloproliferative Neoplasms (Myelofibrosis, PV, ET)

Get Help with Your Treatment

Apply Online or call 1-866-316-7263


Program Status

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.


The PAN Foundation’s Myeloproliferative Neoplasms fund is currently closed. As of February 19, 2018,  CancerCare and Good Days’ Myeloproliferative Disease funds are accepting applications.

Assistance Amount

$8,500 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for the disease named in the assistance program to which he or she is applying.
  2. The patient must have health insurance that covers his or her qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Agrylin (anagrelide hcl)
  • Alkeran (melphalan)
  • Anagrelide Hcl (anagrelide hcl)
  • Aranesp (darbepoetin alfa in polysorbate 80)
  • Bosulif (bosutinib)
  • Busulfex (busulfan)
  • Cladribine (cladribine)
  • Danazol (danazol)
  • Deltasone (prednisone)
  • Depo-Medrol (methylprednisolone acetate)
  • Droxia (hydroxyurea)
  • Exjade (deferasirox)
  • Gleevec (imatinib mesylate)
  • Hydrea (hydroxyurea)
  • Hydroxyurea (hydroxyurea)
  • Iclusig (ponatinib hcl)
  • Imatinib Mesylate (imatinib mesylate)
  • Intron A (interferon alfa-2b,recomb.)
  • Jakafi (ruxolitinib phosphate)
  • Leukeran (chlorambucil)
  • Melphalan Hcl (melphalan hcl)
  • Myleran (busulfan)
  • Pegasys (peginterferon alfa-2a)
  • Pomalyst (pomalidomide)
  • Prednisone (prednisone)
  • Procrit (epoetin alfa)
  • Revlimid (lenalidomide)
  • Sprycel (dasatinib)
  • Sylatron (peginterferon alfa-2b)
  • Synribo (omacetaxine mepesuccinate)
  • Tasigna (nilotinib hcl)
  • Thalomid (thalidomide)

Diagnosis Codes:

ICD-10: C92.10-C92.12, C94.40-C94.42, D45, D46.0-D46.Z, D47.1-D47.Z1